Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Travelers' diarrhea]

A Chagnon1

  • 1Service de médecine interne et maladies tropicales, Institut de médecine navale, Toulon.

La Revue Du Praticien
|January 15, 1996
PubMed
Summary
This summary is machine-generated.

Diarrhoea affects up to 50% of travellers to tropical regions, often caused by enterotoxigenic Escherichia coli. Early fluoroquinolone treatment is recommended for high-risk adults or severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[W. Busch and the enzymes of massive destruction...].

La Revue de medecine interne·2005
Same author

[Rheumatoid carditis: a diagnosis by exclusion].

La Revue de medecine interne·2004
Same author

[An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].

Journal francais d'ophtalmologie·2001
Same author

[Corticoid-sensitive recurrent multifocal superficial thrombophlebitis in an 84-year-old man].

La Revue de medecine interne·1999
Same author

[A painless relapse].

La Revue de medecine interne·1999
Same author

[Extra-capillary glomerulonephritis induced by D-penicillamine therapy].

Presse medicale (Paris, France : 1983)·1999

Area of Science:

  • Microbiology
  • Travel Medicine
  • Infectious Diseases

Context:

  • Travellers' diarrhoea is a common ailment affecting up to 50% of individuals journeying from temperate to tropical or subtropical regions.
  • Enterotoxigenic Escherichia coli (ETEC) is the predominant bacterial pathogen, implicated in 40-70% of diagnosed cases.
  • Laboratory diagnostics are typically reserved for severe, prolonged, or treatment-resistant presentations.

Purpose:

  • To summarize the etiology, incidence, and management strategies for travellers' diarrhoea.
  • To highlight the role of enterotoxigenic Escherichia coli as a primary causative agent.
  • To outline therapeutic and prophylactic considerations for specific risk groups.

Summary:

  • Enterotoxigenic Escherichia coli is the leading bacterial cause of travellers' diarrhoea, a frequent condition among international travellers.

Related Experiment Videos

  • Preventive measures include careful selection of food and beverages.
  • For high-risk adults or those unable to tolerate activity interruption, early fluoroquinolone administration is a viable option, balancing efficacy against potential adverse effects.

    • Impact:

    • Informing travellers and healthcare providers about the risks and prevention of travellers' diarrhoea.
    • Guiding clinical decisions regarding the empirical treatment and chemoprophylaxis of travellers' diarrhoea.
    • Reducing the incidence and impact of travellers' diarrhoea on global mobility and health.